Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

merck-keytruda

MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer

June 11, 2020 Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure

MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …
News
shutterstock_273326141

AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn

June 11, 2020 Research and Development AbbVie, Genmab, partnership, pharma

AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …
News
capture

How digital therapeutics are revolutionising healthcare

June 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital therapeutics, feature, pharma

Digital health covers everything from algorithms identifying new drug combinations, to mobile phone apps to help patient adherence. The past …
Feature
cedrik_britten

Ex-GSK exec named as Chief Medical Officer at Immatics Biotechnologies

June 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, appointment, immatics

Immatics Biotechnologies welcomed former GlaxoSmithKline executive Dr Cedrik Britten to the company as its new Chief Medical Officer (CMO) on …
Appointment
nhsyyy

Number of people waiting for NHS treatment could double to 10 million due to pandemic

June 10, 2020 Research and Development COVID-19, coronavirus

The backlog of people waiting for treatment on the NHS could reach as high as 10 million people by Christmas …
News
vertex-headquarters

Vertex scores EU approval for cystic fibrosis drug Kalydeco in R117H+ children and adolescents

June 10, 2020 Research and Development, Sales and Marketing Kalydeco, Vertex, cystic fibrosis, ivacaftor, pharma

Vertex has revealed that it has secured a new approval from the European Commission for its therapy Kalydeco (ivacaftor) in …
News
covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 10, 2020 Research and Development COVID-19, coronavirus, round up, top 10

Hydroxychloroquine as a potential coronavirus treatment continues to be a contentious issue, as a new study led by researchers at …
News

Lundbeck to restructure R&D, shedding up to 160 jobs

June 10, 2020 Manufacturing and Production, Research and Development Lundbeck, pharma, staff cuts

Danish neuroscience specialist Lundbeck has announced it will be implementing a restructure of its Research & Development operations – a …
News
triallyyy

US trial of ivermectin cuts coronavirus mortality by 40%

June 10, 2020 Research and Development COVID-19, coronavirus

A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%. …
News
alnylam_credit_-_business_wire

Alnylam’s lumasiran hits main Phase 3 goal in rare renal disease primary hyperoxaluria type 1

June 9, 2020 Manufacturing and Production, Research and Development Alnylam, lumasiran, pharma, rare disease

Alnylam has presented promising new Phase 3 data at the European Renal Association-European Dialysis and Transplant Association International Congress for …
News
astrazeneca_sign_sky

AstraZeneca’s BTK inhibitor Calquence shows promise in aiding recovery of severe COVID-19 patients

June 8, 2020 Research and Development, Sales and Marketing AstraZeneca, COVID-19, Calquence, coronavirus, pharma

AstraZeneca has revealed more data in its efforts to find an effective therapy for those affected by the novel coronavirus.
News
stacey

Stacey Coen appointed Senior Vice President and Chief Business Officer at ImmunoGen

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

ImmunoGen have appointed Stacey Coen as their new Senior Vice President and Chief Business Officer. She joins the company from …
Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

This week has seen the development of coronavirus vaccines move forward, as the Trump administration has selected the finalists for …
News
novartis_outside_1

Novartis’ Cosentyx hits primary goal in Phase 3 non-radiographic axial spondyloarthritis study

June 4, 2020 Research and Development Cosentyx, Novartis, axial spondyloarthritis

New Phase 3 data has been released on the efficacy of Novartis’ interleukin (IL)-17A inhibitor Cosentyx (secukinumab), showing that the …
News
janssen_latest_logo_on_sign_closer

Janssen’s Tremfya shows skin clearance benefit for psoriatic arthritis patients in two Phase 3 studies

June 4, 2020 Research and Development Janssen, Tremfya, psoriatic arthritis

Janssen has revealed data from two Phase 3 trials for Tremfya (guselkumab), showing improvement in skin clearance and symptoms in …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026